Alan S. Roemer
Principal Fin & Acct Officer, Sio Gene Therapies Inc.
Companies
- IN8BIO, INC.Board member Jul 29, 2021 to now1
- NexImmune, Inc.Board member Feb 11, 2021 to Nov 22, 20232
- Sio Gene Therapies Inc.Principal Fin & Acct Officer Jun 10, 2015 to Jun 10, 20153
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- IN8BIO, INC. INAB49,514 shares4$58.1K at $1.17Dec 22, 2025
- NexImmune, Inc.0 shares5Nov 22, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 22, 2025Granted 36,232 shares at $1.38 of IN8BIO, INC.4
- Apr 30, 2025Exercised options 11,000 shares at $0.18 of IN8BIO, INC.6
- Apr 30, 2025Exercised options 102,459 shares at $0.18 of IN8BIO, INC.6
- Oct 4, 2024Granted 126,582 shares of IN8BIO, INC.7
- Dec 13, 2023Granted 102,459 shares of IN8BIO, INC.8
- Nov 22, 2023Sold 3,992 shares at $1.94 of NexImmune, Inc.5
- Nov 21, 2023Sold 3,833 shares at $2.16 of NexImmune, Inc.5
- Aug 16, 2022Bought 26,315 shares at $1.90 of IN8BIO, INC.9
- Dec 21, 2021Exercised options 42,389 shares at $4.31 of NexImmune, Inc.10
- Dec 21, 2021Exercised options 12,634 shares at $2.58 of NexImmune, Inc.10
- Dec 21, 2021Exercised options 12,634 shares at $2.42 of NexImmune, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARIN8BIO, INC., Board member
- 2SEC EDGARNexImmune, Inc., Board member
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed May 7, 2025
- 7SEC EDGARForm 4 filed Oct 8, 2024
- 8SEC EDGARForm 4 filed Dec 15, 2023
- 9SEC EDGARForm 4 filed Aug 18, 2022
- 10SEC EDGARForm 4 filed Dec 22, 2021